# Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)

> **NCT02173964** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 58 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** pinaverium bromide
- **DRUG:** water

## Key facts

- **NCT ID:** NCT02173964
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2016-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02173964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02173964, "Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02173964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*